EPISODE · Oct 9, 2024 · 4 MIN
Aldeyra Resubmits NDA for DED Drug Reproxalap
from Eyewire News: The Podcast · host Eyewire News
Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and Bausch + Lomb launches a new digital e-commerce marketplace. Learn more about your ad choices. Visit megaphone.fm/adchoices
What this episode covers
Aldeyra resubmits its NDA for dry eye drug reproxalap; Clearside announces new phase 2b topline data for its investigational extended-release wet AMD drug; and Bausch + Lomb launches a new digital e-commerce marketplace. Learn more about your ad choices. Visit megaphone.fm/adchoices
NOW PLAYING
Aldeyra Resubmits NDA for DED Drug Reproxalap
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m